Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant

PURPOSE: To assess short-term functional and anatomical outcomes of refractory diabetic macular edema (DME) following a switch from ranibizumab or dexamethasone to aflibercept. METHODS: We included retrospectively eyes with persistent DME after at least 3 ranibizumab and/or one dexamethasone implant...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Ophthalmol
मुख्य लेखकों: Herbaut, Antoine, Fajnkuchen, Franck, Qu-Knafo, Lise, Nghiem-Buffet, Sylvia, Bodaghi, Bahram, Giocanti-Auregan, Audrey
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Hindawi 2017
विषय:
Clinical Study
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5576400/
https://ncbi.nlm.nih.gov/pubmed/28900543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8035013
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन